Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.201
-0.059 (-4.68%)
Jan 31, 2025, 4:00 PM EST - Market closed
Citius Oncology Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| FY 2024 | FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
| Selling, General & Admin | 15.65 | 7.88 | 2.86 |
| Research & Development | 4.93 | 4.24 | 6.86 |
| Operating Expenses | 20.57 | 12.12 | 9.71 |
| Operating Income | -20.57 | -12.12 | -9.71 |
| Pretax Income | -20.57 | -12.12 | -9.71 |
| Income Tax Expense | 0.58 | 0.58 | 1.15 |
| Net Income | -21.15 | -12.7 | -10.87 |
| Net Income to Common | -21.15 | -12.7 | -10.87 |
| Shares Outstanding (Basic) | 68 | 68 | 34 |
| Shares Outstanding (Diluted) | 68 | 68 | 34 |
| Shares Change (YoY) | 0.82% | 100.00% | - |
| EPS (Basic) | -0.31 | -0.19 | -0.32 |
| EPS (Diluted) | -0.31 | -0.19 | -0.32 |
| Free Cash Flow | 0.13 | - | - |
| Free Cash Flow Per Share | 0.00 | - | - |
| EBIT | -20.57 | -12.12 | -9.71 |
Source: S&P Capital IQ. Standard template.
Financial Sources.